Seq |
Description |
Document |
Type |
Size |
1 |
ANNUAL REPORT |
ea0200896-10k_oramedph.htm iXBRL |
10-K |
1545523 |
2 |
AMENDMENT, DATED APRIL 27, 2023, TO CONSULTING AGREEMENT BY AND BETWEEN ORAMED P |
ea0200896ex10-2_oramed.htm |
EX-10.2 |
12844 |
3 |
AMENDMENT, DATED JANUARY 8, 2024, TO CONSULTING AGREEMENT BY AND BETWEEN ORAMED |
ea0200896ex10-3_oramed.htm |
EX-10.3 |
8697 |
4 |
AMENDMENT, DATED APRIL 27, 2023, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED L |
ea0200896ex10-5_oramed.htm |
EX-10.5 |
8926 |
5 |
AMENDMENT, DATED JANUARY 8, 2024, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED |
ea0200896ex10-6_oramed.htm |
EX-10.6 |
6234 |
6 |
AMENDMENT, DATED APRIL 27, 2023, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAMED |
ea0200896ex10-15_oramed.htm |
EX-10.15 |
12573 |
7 |
AMENDMENT, DATED JANUARY 8, 2024, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAMED |
ea0200896ex10-16_oramed.htm |
EX-10.16 |
8574 |
8 |
THIRD AMENDMENT, DATED APRIL 27, 2023, TO EMPLOYMENT AGREEMENT, BY AND BETWEEN O |
ea0200896ex10-20_oramed.htm |
EX-10.20 |
9214 |
9 |
FOURTH AMENDMENT, DATED JANUARY 8, 2024, TO EMPLOYMENT AGREEMENT, BY AND BETWEEN |
ea0200896ex10-21_oramed.htm |
EX-10.21 |
6886 |
10 |
REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS |
ea0200896ex10-22_oramed.htm |
EX-10.22 |
86336 |
11 |
CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM |
ea0200896ex23-1_oramed.htm |
EX-23.1 |
1943 |
12 |
CERTIFICATION |
ea0200896ex31-1_oramed.htm |
EX-31.1 |
9950 |
13 |
CERTIFICATION |
ea0200896ex31-2_oramed.htm |
EX-31.2 |
11198 |
14 |
CERTIFICATION |
ea0200896ex32-1_oramed.htm |
EX-32.1 |
3398 |
15 |
CERTIFICATION |
ea0200896ex32-2_oramed.htm |
EX-32.2 |
3334 |
16 |
ORAMED PHARMACEUTICALS INC. CLAWBACK POLICY, ADOPTED NOVEMBER 9, 2023 |
ea0200896ex97-1_oramed.htm |
EX-97.1 |
40896 |
17 |
GRAPHIC |
image_001.jpg |
GRAPHIC |
2132 |
18 |
GRAPHIC |
ex97-1_001.jpg |
GRAPHIC |
2260 |
|
Complete submission text file |
0001213900-24-020485.txt |
|
8257559 |